Who backs AgomAb?
17 investors| Investor | Type |
|---|---|
| Fidelity Management & Research Company | Asset manager |
| Canaan Partners | Venture capital |
| The Invus Group | PE / buyout |
| Cormorant Asset Management | Venture capital |
| EQT Life Sciences | Venture capital |
| Omnes Capital | PE / buyout |
| Andera Partners | PE / buyout |
| Boehringer Ingelheim Venture Fund | Other |
| Redmile Group | PE / buyout |
| Asabys Partners | Venture capital |
| + 7 more investors · a free account shows the complete list | |
The directory is free. Check sizes and activity — the working columns — are Pro.Unlock prospecting columns
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 17 names
- ·Watchlist + deal alerts for AgomAb
Create free account
No card required
For fundraisers
Work this list, don’t just read it
These 17 firms already write checks for companies like AgomAb in drug discovery. Build the wider list: every firm that has backed a company like this one, ranked by how often and how recently.